Impact of Race/Ethnicity on Clinical and Genomic Characteristics, Trial Participation, and Genotype-Matched Therapy among Patients with Metastatic Breast Cancer
Racial/ethnic minority patients were less likely to receive matched therapy. Further research is needed to identify barriers to precision medicine.
Authors
- Rupali Sood (ORCID: https://orcid.org/0000-0001-6073-5832)
- Beverly Moy (ORCID: https://orcid.org/0000-0003-3472-1140)
- Laura M. Spring (ORCID: https://orcid.org/0000-0001-8904-3514)
- Andrzej Niemierko (ORCID: https://orcid.org/0000-0002-8895-5500)
- Aditya Bardia (ORCID: https://orcid.org/0000-0003-4885-1157)
- Neelima Vidula (ORCID: https://orcid.org/0000-0002-5963-7052)
- Lianne Ryan
Institutions
- University of California, Los Angeles (US)
- Massachusetts General Hospital (US)
- Center for Cancer Research (US)
Publication Details
- Journal
- Clinical Cancer Research
- Published
- 2025-01-27
- DOI
- https://doi.org/10.1158/1078-0432.ccr-24-2825
- Citations
- 2
- Primary Topic
- BRCA gene mutations in cancer
- Type
- article
- Field-Weighted Citation Impact
- 3.63